Skip to main content
Download PDF

Age-associated network controllability changes in first episode drug-naïve schizophrenia

BMC Psychiatry volume 22, Article number: 26 (2022) Cite this article

Abstract

Background

Recent neuroimaging studies revealed dysregulated neurodevelopmental, or/and neurodegenerative trajectories of both structural and functional connections in schizophrenia. However, how the alterations in the brain’s structural connectivity lead to dynamic function changes in schizophrenia with age remains poorly understood.

Methods

Combining structural magnetic resonance imaging and a network control theory approach, the white matter network controllability metric (average controllability) was mapped from age 16 to 60 years in 175 drug-naïve schizophrenia patients and 155 matched healthy controls.

Results

Compared with controls, the schizophrenia patients demonstrated the lack of age-related decrease on average controllability of default mode network (DMN), as well as the right precuneus (a hub region of DMN), suggesting abnormal maturational development process in schizophrenia. Interestingly, the schizophrenia patients demonstrated an accelerated age-related decline of average controllability in the subcortical network, supporting the neurodegenerative model. In addition, compared with controls, the lack of age-related increase on average controllability of the left inferior parietal gyrus in schizophrenia patients also suggested a different pathway of brain development.

Conclusions

By applying the control theory approach, the present study revealed age-related changes in the ability of white matter pathways to control functional activity states in schizophrenia. The findings supported both the developmental and degenerative hypotheses of schizophrenia, and suggested a particularly high vulnerability of the DMN and subcortical network possibly reflecting an illness-related early marker for the disorder.

Peer Review reports

Background

Schizophrenia is increasingly conceptualized as a disorder with abnormal neurodevelopmental, or/and neurodegenerative connectivity trajectories [1, 2]. The neurodevelopmental hypothesis indicated that genetic and early-life environmental risk factors may alter neurodevelopmental synaptic plasticity (such as synaptogenesis and synaptic pruning) [3], and result in the concomitant disruption of balanced interplay between integration and segregation of both structural and functional brain networks [4], and ultimately alter neurodevelopment trajectories to the onset of schizophrenia during late adolescence or early adulthood [1, 5]. Supporting the neurodevelopment models, the neuroimaging studies have revealed aberrant developmental trajectories in schizophrenia, for example, the delayed development of brain connectivity [6] and dysregulated maturation of the functional connectivity [7].

On the other hand, the neurodegenerative models identify schizophrenia as a progressive neurodegenerative disease [2, 8]. The prior findings of accelerated aging in gray matter [9, 10], white matter [11, 12] and large-scale functional brain networks in schizophrenia [13] provided evidence supporting the neurodegenerative model underlying schizophrenia. In this context, schizophrenia might be a disorder that incorporates both neurodevelopmental and neurodegenerative processes, but which brain regions/networks are specific to each of them remains to be established.

Notably, the alterations of the brain’s structure (such as myelination and white matter integrity) have critical implications for function which reflects the coordinated neural activity between different brain regions [14, 15]. Understanding the mechanism by which structure evolves to support the coordination of neural activity, would have far-reaching implications for our understanding of vulnerabilities to schizophrenia.

The recently developmental network control theory can simulate consequences of structural connections on function dynamics [16]. In the network control model, the brain is constructed of networks defined by structural connection, while the neural state is defined by a linear dynamic model [16, 17]. Network controllability is a structural predictor of the capability of steering network states to any configuration through external control [16, 18]. Average controllability as a network controllability metric quantifies capacity of brain regions or networks to steer the system to many easily reachable states, is a structural phenotype predicted to facilitate small changes in brain state [16]. The network control theory has been used in uncovering the underlying structural mechanism of macroscale brain dysfunction in multiple psychiatric and neurological disorders, such as bipolar disorder [19], schizophrenia [20], Parkinson’s disease [21] and epilepsy [22]. A recent study on network controllability of psychosis spectrum disorders further indicated that average controllability can predict positive psychosis spectrum symptoms better than all other network connectivity characteristics, considering the impact of both direct and indirect structural connectivity on the spread of activity [23]. In healthy controls, it has also been shown that network controllability measurements dynamically change during neurodevelopment [18], and support the development of executive function during youth [24]. However, to our knowledge, no studies have investigated age-related changes of network controllability in untreated schizophrenia patients to date.

The present work aimed to characterize age-related network controllability alterations in a relatively large sample of drug-naïve schizophrenia patients. As network controllability abnormality has been suggested as illness-trait of brain functioning in psychiatric disorder, characterizing the changes along aging might be more informative for locating the changes specific to neurodevelopmental/neurodegenerative processes. In the exploratory analysis, average controllability alterations were related to clinical features of schizophrenia. We hypothesized that schizophrenia patients would show differences in age-related trajectories of network control properties relative to healthy controls.

Methods

Participants

This present study included 175 patients with drug-naïve schizophrenia (SCZ) and 155 healthy controls (HCs) between 16 and 60 years of age. All participants were right-handed and of Han ancestry, and recruited at the West China Hospital from September 2005 to May 2014 (see Table 1 for demographic and clinical characteristics of all participants). Diagnosis of schizophrenia was determined using the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). Illness onset was determined using the Nottingham Onset Schedule [25], while psychiatric illness severity was assessed using the Positive and Negative Syndrome Scale (PANSS) and the Global Assessment Function (GAF) scale. Healthy controls were recruited from local communities through advertisement, and had no personal history or known history of major psychiatric illness in first-degree relatives. Other exclusion criteria for both two groups included current or past substance abuse, current pregnancy, significant systemic medical illness that might impact brain measures, history of neurological disorder or neurosurgery and MRI contraindications.

Table 1 Demographic and clinical information of drug-naïve schizophrenia patients and healthy control participants
Full size table

Notably, drug-naive schizophrenia patients were identified by a regional Mental Health Screening Program designed to identify and then provide psychiatric care to individuals with serious but untreated mental illness. There are 17 drug-naïve patients with long-term schizophrenia aged from 36 to 60 years. Most lived in small rural villages, and had not received any prior psychiatric treatment for various reasons, primarily because of parental concern about family stigma; a lack of understanding of the severity of the mental illness; poor socioeconomic conditions that limited travel and funds for medical care; and conflicts with physicians when the patient was first brought to medical attention close the time of illness onset. Each patient had been cared for and sheltered in their parents’ home without medical care through the course of their illness.

MRI data acquisition

All MRI scans including diffusion tensor imaging (DTI) and high-resolution T1-weighted imaging were conducted on a 3T MRI scanner (EXCITE, General Electric). The DTI data were acquired using a single-shot spin-echo echo-planar image sequence: repetition time (TR) = 1000 ms, echo time (TE) = 70.8 ms, field of view (FOV) = 240 mm×240 mm, voxel size = 1.8 × 1.8 × 3.0 mm3, and slice thickness = 3.0 mm with no interslice gap. Each DTI data set included 15 non-collinear directions (b = 1000 s/mm2) and a reference image without diffusion weighting (b = 0 s/mm2). The high-resolution T1-weighted images were obtained using a spoiled gradient recall sequence: TR = 8.5 ms, TE = 3.4 ms, flip angle = 12°, Inversion time = 400 ms, FOV = 240 mm×240 mm, voxel size = 0.47 × 0.47 × 1 mm3, slice thickness = 1 mm with no gap and 156 slices. Two experienced neuroradiologists (Tang and Zhang) separately inspected MR images to exclude data with gross brain abnormalities or visible artifacts.

Data preprocessing and network construction

Preprocessing of DTI data was conducted with the Pipeline for Analyzing Brain Diffusion Images toolkit (PANDA, http://www.nitrc.org/projects/panda), including head motion correction, eddy current correction, the voxel-wise tensor matrix and diffusion tensor metrics (such as fractional anisotropy (FA), the primary measure of interest) calculation. We used the atlas of Lausanne 2008 [26, 27] to parcellate the entire brain into 220 cortical and 14 subcortical regions (the bilateral thalamus proper, caudate, putamen, pallidum, accumbens area, hippocampus, and amygdala).

The FA is the most widely used DTI measures, could primarily reflect the myelin integrity, and quantify the fiber integrity of the connections [28, 29]. Thus, FA values between the end-nodes were used as the connectivity weight between two nodes, then a 234 × 234 weighted matrix for each participant was obtained. To define priori network, each cortical Lausanne label was assigned to a functional system defined by Yeo et al. [30], by calculating the purity index for the 7-system parcellation and 234 brain regions from the Lausanne atlas. The purity index quantifies the maximum overlap of cortical Lausanne labels and 7-system parcellation [31]. The 7-system parcellation include Default Mode Network (DMN), Dorsal Attention Network (DA), Frontoparietal Control Network (FCN), Limbic Network (LN), Somatomotor Network (SMN), Visual Network (VN), Ventral Attention Network (VA). Subcortical nodes were assigned to an eighth network based on the prior study [31].

Network controllability

The network control theory can simulate consequences of a network’s underlying structural topology on its function dynamics [15, 32, 33]. The present study applied the network control theory framework to calculate network controllability, following prior work [16, 18, 24, 25, 34,35,36], implemented in MATLAB with in-house packages and code. The two essential components of this approach are structural connections and a linear dynamic model which defines the activity state of the brain and describes dynamic transition between functional states [16, 17]. Base on the previous studies, we define structural connectivity networks by subdividing the entire brain into 234 anatomically distinct brain areas (network nodes) on the basis of tractography data in humans [18, 26]. We define the of neural dynamics by drawing on prior models predicting human resting state functional dynamics from structural connectivity [15, 16]. The validity of this model offering mechanistic predictors of network dynamics on the basis of diffusion data rather than real fMRI data has previously been demonstrated based on extensive prior work in human systems neuroscience [15]. The details of dynamic model are provided in Supplementary Materials.

Network controllability refers to the possibility of steering network states to any configuration through external control. Average controllability as a network controllability metric quantifies capacity of brain regions or networks to steer the system to many easily reachable states [16]. Regions or networks with higher average controllability are thought to have greater potential impact on network dynamic control [16]. Detailed derivation of average controllability is provided in Supplementary Materials.

Statistical analyses

Age-related changes of network controllability

Statistical analyses were performed using the SPSS software (Statistical Product and Service Solutions for Windows version 24.0, https://www.ibm.com/analytics/spss-statistics-software). In the primary analysis, linear model was adopted to examine the age-related changes of network controllability based on the prior work showing white matter (WM) microstructure changed linearly with age in healthy controls [37]. During the analysis, general linear model (GLM) was used to predict WM network controllability with diagnosis (SCZ, HC), age, and diagnosis by age interaction being the dependent variables, while sex and education years were treated as covariates. The GLM was repeated for each one of the 8 networks and 234 nodes respectively, the findings were corrected by false discovery rate (FDR) to preserve a p < 0.05 experiment-wise threshold. For the networks or nodes with significant diagnosis by age interactions on network controllability, which indicates that there are significant differences in the modeled age-related changing trajectories between diagnostic groups, regression curves were established to precisely depict the associations between network controllability and age in the patient group and control group respectively, with sex and education years as covariates.

Subsequently, to further map the age-related patterns of network controllability in the SCZ, we also used the stage-specific approach that has been used in previous research [7]. Previous lifespan studies showed that peak FA values and minimum mean diffusivity (MD) values mostly occur before 35 years [38]. Therefore, in the present study, 35 years was chosen as a cut-off to divide all participants into two age subgroups (adolescents and young adults: age 16-35 years, 133 patients, 116 controls; late adults: age 36-60 years, 42 patients, 39 controls, see Table S1 for demographic and clinical characteristics of participants in each age subgroup). Then, we assessed the interaction effect between diagnosis and age subgroup (16-35 years, 36-60 years) on network controllability, as well as the interaction effect between diagnosis and age on network controllability in each age subgroup using GLM. Sex and education years were controlled in these analyses. For explanatory purposes, we performed the subgroup analysis in networks and regions with significant age-related controllability alterations which found in the primary analysis, thus the findings of subgroup analysis were not corrected for multiple comparisons for these heuristic analyses.

Correlations between network controllability and clinical characteristics

For networks and nodes with significant age-related network controllability changes, two-tailed partial correlations were performed to examine the associations between the network controllability with duration of untreated psychosis (DUP) and symptom severity, controlling age, sex and education years. Statistical significance of correlations was set at p < 0.05 after correction with FDR.

Results

Age-related changes of network controllability

At the network level, there was a significant main effect of diagnosis by age interaction (F = 7.94, p = 0.040) and diagnosis (F = 9.30, p = 0.016, SCZ < HC) on the average controllability of DMN. Further analysis revealed that the patients with schizophrenia had lower average controllability than healthy controls, but showed no significant age-related change on average controllability of DMN network (r = 0.11, p = 0.148), while healthy controls showed significant age-related decline on average controllability of DMN (r = −0.17, p = 0.036) (Fig. 1). We also observed significant diagnosis by age interaction (F = 4.76, p = 0.030, uncorrected) on the average controllability of subcortical network. Further analysis revealed that the patients with schizophrenia showed significant age-related decline on average controllability of subcortical network (r = −0.19, p = 0.011), while healthy controls showed no significant age-related change (r = 0.11, p = 0.195) (Fig. 1).

Fig. 1
figure 1

Linear modeling of age effects on network-level average controllability in drug-naïve schizophrenia patients and healthy controls. Diagnosis by age interactions were significant for the default mode network (p = 0.040) and the subcortical network (p = 0.030, uncorrected). Abbreviations: SCZ-schizophrenia, HC-healthy control

Full size image

At the nodal level, our findings revealed a significant main effect of diagnosis by age interaction (F = 13.80, p < 0.001) and diagnosis (F= 13.78, p < 0.001, SCZ < HC) on the average controllability of left inferior parietal gyrus. Further analysis indicated a higher average controllability of this region in healthy controls than schizophrenia patients, accompanied by a significant age-related increase of the network controllability measure in HC (r = 0.21, p = 0.009) and no significant age-related change in SCZ (r = -0.06, p = 0.448) (Fig. 2). In addition, there was significant interaction of diagnosis by age (F = 9.44, p = 0.002, uncorrected) on the average controllability of the right precuneus, driven by significant age-related decrease on average controllability of the right precuneus in HC (r = −0.28, p = 0.001) and no significant age-related change in SCZ (r = 0.08, p = 0.269) (Fig. 2).

Fig. 2
figure 2

Linear modeling of age effects on node-level average controllability in drug-naïve schizophrenia patients and healthy controls. Diagnosis by age interactions reached significance for the left inferior parietal gyrus (p < 0.001) and the right precuneus (p = 0.002, uncorrected) at the level of node. Abbreviations: SCZ-schizophrenia, HC-healthy control, R-right, L-left

Full size image

Since the lower education years in schizophrenia patients might be directly related to the illness, we also replicated the age-related controllability analyzes in schizophrenia without controlling education years. Notably, the main findings remained stable with or without controlling education years (see Supplementary Materials for details).

In line with our findings of diagnosis by age interaction effects in the primary analysis, the findings of subgroup analysis indicated that the subcortical network, DMN and the left inferior parietal gyrus were the main network/regions with age-related average controllability changes in schizophrenia (see Supplementary Materials for details, Fig. S1).

Associations between network controllability and clinical characteristics

In the patient group, there were no significant correlation between average controllability measures and DUP, GAF scores, or PANSS scores after controlling age, sex and education years.

Discussion

The network control theory can offer a mechanistic explanation for how the brain moves between functional states on the basis of white matter microstructure [16]. We use average controllability, as structural predictor of brain dynamics, to quantify ability of specific brain regions or networks to steer the system to many easily reachable states. The present study combined diffusion MRI and a network control theory approach to investigate the aberrant age-related alterations of average controllability in drug-naïve schizophrenia patients. Compared with controls, schizophrenia patients showed differences in age-related model of average controllability in DMN and subcortical network at the level of network, as well as the right precuneus and left inferior parietal gyrus at the nodal level. Notably, the schizophrenia patients demonstrated the lack of age-related decrease on average controllability of DMN network, as well as the right precuneus (a hub region of the DMN), suggesting an aberrant narrowing or specialization of their preferred control roles with age, providing additional support for the neurodevelopmental hypothesis of schizophrenia. Furthermore, the schizophrenia patients demonstrated accelerated age-related decline of average controllability in the subcortical network, indicating accelerated age-related decline of ability of the subcortical network to shift brain function into the optimal context-appropriate brain state, and supporting the neurodegenerative model. Taken together, the findings suggest that the DMN and subcortical network may be particularly vulnerable to the maturational and degenerative process in schizophrenia respectively, and contribute to the growing evidence that network controllability metrics might represent illness-related early biomarkers.

Age-related changes of network controllability

Healthy controls in the present study displayed an age-related decline in average controllability of the DMN, as well as the right precuneus, which may be the result of a fine-tuning of the structural organization in an optimized way for diverse functional dynamics with maturation [18]. In contrast, schizophrenia patients didn’t display age-related change in the average controllability metrics of DMN, possibly mirroring the dysregulated maturational processes, in which underlying anatomical connections changes caused by aberrant synaptic pruning and myelination lead to altered functional integration and segmentation of DMN [14, 15]. Previous studies revealing functional disturbance of the DMN in patients with schizophrenia and the relatives, suggested a genetic factor for the impairments of functional development on DMN [39, 40]. The abnormal network controllability changes of DMN revealed the disruption of the functional balance between the DMN and other task-relevant brain systems which needed to bring cognitive resources to bear to respond adaptively to current environmental demands [41,42,43].

Consistent with previous findings, the present study showed that network controllability metric of the subcortical network in healthy controls did not significantly change with age, indicating that subcortical regions are stable controllers [18]. Relative to controls, the age-related decrease on average controllability of subcortical network in schizophrenia patients may indicate dysregulated degenerative trajectories in schizophrenia, consistent with accelerated aging of subcortical structures in schizophrenia [9, 44]. The dysregulated degenerative trajectory of WM network controllability in schizophrenia may result from the underlying anatomical changes and subcortical dopamine dysregulation via aberrant reactions within the stress-response circuity [5, 45].

Compared with controls, the lack of age-related increase on average controllability of the left inferior parietal gyrus in schizophrenia patients may suggest a different pathway of brain development consistent with similar findings of deficits in the parietal cortices in adolescent siblings of patients with schizophrenia [46].

Associations between network controllability and clinical characteristics

Importantly, aberrant network controllability metrics were not associated with DUP, suggesting that alterations in these networks and regions might reflect early markers of schizophrenia. The present study did not observe associations between brain network controllability properties and symptom severity, possibly reflecting that network controllability might not directly relate to the current symptom at the onset of the disorder and might be relevant to the illness trait of schizophrenia.

Limitations

There are several limitations that should be considered when interpreting the current results. First, our data is cross-sectional, limiting the ability to make causal inferences about network controllability changes across the lifespan of schizophrenia patients. The longitudinal experimental designs can trace the precise trajectories of brain changes theoretically throughout the course of illness. However, such studies will inevitably incorporate the confounding effects of antipsychotic drugs. Alternatively, cross-sectional designs with a large number of participants can also model age-related brain changes, especially preferable when treatment effects need to be excluded, and have frequently been used to investigate progressive brain changes [9, 11]. Second, schizophrenia typically appears in adolescents and young adults, and our samples were not perfectly distributed across the entire lifespan--the number of young adults was greater than thatof older participants. The uneven distribution of age in our sample may affect the mapping of age-related network controllability trajectories. Future studies with larger samples, especially with more older participants, are required to validate our findings. Third, there is no consensus of approach for calculating network metrics, and we used the FA values as the structural network connectivity weight. Other measures such as the MD or number of fibers could also be considered as weighting factors. Finally, some other clinical features such as cognition and blood tests were not systematically assessed, future work is required to comprehensively determine the clinical correlates and mechanisms of our findings.

Conclusions

By modeling network controllability with age in untreated schizophrenia, the present study illustrated aberrant age-related changes in ability of white matter pathways to control functional activity states relative to healthy controls. The findings supported both the developmental and degenerative hypotheses of illness course of schizophrenia, and suggested a particularly high vulnerability of the DMN and subcortical network possibly reflecting an illness-related early marker for the disorder.

Availability of data and materials

The datasets generated and/or analyzed during the current study are not publicly available due to that they contain patients’ personal information and our hospital has strict data sharing policy, but they are available from the corresponding author on reasonable request.

Abbreviations

DMN:

default mode network

SCZ:

schizophrenia

HC:

healthy controls

PANSS:

Positive and Negative Syndrome Scale

GAF:

Global Assessment Function scale

DTI:

diffusion tensor imaging

TR:

repetition time

TE:

echo time

FOV:

field of view

FA:

fractional anisotropy

WM:

white matter

GLM:

general linear model

FDR:

false discovery rate

MD:

mean diffusivity

DUP:

duration of untreated psychosis

References

  1. Rapoport JL, Giedd JN, Gogtay N: Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry 2012, 17(12):1228–1238.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Kochunov P, Hong LE: Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage. Schizophr Bull 2014, 40(4):721–728.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Huttenlocher PR: Synaptic density in human frontal cortex - developmental changes and effects of aging. Brain Res 1979, 163(2):195–205.

    Article  CAS  PubMed  Google Scholar 

  4. Blakemore SJ, Choudhury S: Development of the adolescent brain: implications for executive function and social cognition. J Child Psychol Psychiatry 2006, 47(3-4):296–312.

    Article  PubMed  Google Scholar 

  5. McCutcheon RA, Reis Marques T, Howes OD: Schizophrenia-an overview. JAMA Psychiatry 2020, 77(2):201–210.

    Article  PubMed  Google Scholar 

  6. Zalesky A, Pantelis C, Cropley V, Fornito A, Cocchi L, McAdams H, Clasen L, Greenstein D, Rapoport JL, Gogtay N: Delayed development of brain connectivity in adolescents with schizophrenia and their unaffected siblings. JAMA Psychiatry 2015, 72(9):900–908.

    Article  PubMed  Google Scholar 

  7. Li M, Becker B, Zheng J, Zhang Y, Chen H, Liao W, Duan X, Liu H, Zhao J, Chen H: Dysregulated maturation of the functional connectome in antipsychotic-naive, first-episode patients with adolescent-onset schizophrenia. Schizophr Bull 2019, 45(3):689–697.

    Article  PubMed  Google Scholar 

  8. Andreasen NC, Nopoulos P, Magnotta V, Pierson R, Ziebell S, Ho BC: Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol Psychiatry 2011, 70(7):672–679.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Cropley VL, Klauser P, Lenroot RK, Bruggemann J, Sundram S, Bousman C, Pereira A, Di Biase MA, Weickert TW, Weickert CS et al: Accelerated gray and white matter deterioration with age in schizophrenia. Am J Psychiatry 2017, 174(3):286–295.

    Article  PubMed  Google Scholar 

  10. Zhang W, Deng W, Yao L, Xiao Y, Li F, Liu J, Sweeney JA, Lui S, Gong Q: Brain structural abnormalities in a group of never-medicated patients with long-term schizophrenia. Am J Psychiatry 2015, 172(10):995–1003.

    Article  PubMed  Google Scholar 

  11. Cetin-Karayumak S, Di Biase MA, Chunga N, Reid B, Somes N, Lyall AE, Kelly S, Solgun B, Pasternak O, Vangel M et al: White matter abnormalities across the lifespan of schizophrenia: a harmonized multi-site diffusion MRI study. Mol Psychiatry 2020:25(12):3208–19.

  12. Wright S, Kochunov P, Chiappelli J, McMahon R, Muellerklein F, Wijtenburg SA, White MG, Rowland LM, Hong LE: Accelerated white matter aging in schizophrenia: role of white matter blood perfusion. Neurobiol Aging. 2014;35(10):2411–18.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Sheffield JM, Repovs G, Harms MP, Carter CS, Gold JM, MacDonald AW, 3rd, Ragland JD, Silverstein SM, Godwin D, Barch DM: Evidence for accelerated decline of functional brain network efficiency in schizophrenia. Schizophr Bull 2016;42(3):753–61.

  14. Cornblath EJ, Ashourvan A, Kim JZ, Betzel RF, Ciric R, Adebimpe A, Baum GL, He X, Ruparel K, Moore TM et al: Temporal sequences of brain activity at rest are constrained by white matter structure and modulated by cognitive demands. Commun Biol 2020, 3(1):261.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Honey CJ, Sporns O, Cammoun L, Gigandet X, Thiran JP, Meuli R, Hagmann P: Predicting human resting-state functional connectivity from structural connectivity. Proc Natl Acad Sci U S A 2009, 106(6):2035–2040.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Gu S, Pasqualetti F, Cieslak M, Telesford QK, Yu AB, Kahn AE, Medaglia JD, Vettel JM, Miller MB, Grafton ST et al: Controllability of structural brain networks. Nat Commun 2015, 6:8414.

    Article  CAS  PubMed  Google Scholar 

  17. Gu S, Betzel RF, Mattar MG, Cieslak M, Delio PR, Grafton ST, Pasqualetti F, Bassett DS: Optimal trajectories of brain state transitions. Neuroimage 2017, 148:305–317.

    Article  PubMed  Google Scholar 

  18. Tang E, Giusti C, Baum GL, Gu S, Pollock E, Kahn AE, Roalf DR, Moore TM, Ruparel K, Gur RC et al: Developmental increases in white matter network controllability support a growing diversity of brain dynamics. Nat Commun 2017, 8(1):1252.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Jeganathan J, Perry A, Bassett DS, Roberts G, Mitchell PB, Breakspear M: Fronto-limbic dysconnectivity leads to impaired brain network controllability in young people with bipolar disorder and those at high genetic risk. Neuroimage Clin 2018, 19:71–81.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Braun U, Harneit A, Pergola G, Menara T, Schafer A, Betzel RF, Zang Z, Schweiger JI, Zhang X, Schwarz K et al: Brain network dynamics during working memory are modulated by dopamine and diminished in schizophrenia. Nat Commun 2021, 12(1):3478.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Zarkali A, McColgan P, Ryten M, Reynolds R, Leyland LA, Lees AJ, Rees G, Weil RS: Differences in network controllability and regional gene expression underlie hallucinations in Parkinson’s disease. Brain 2020, 143(11):3435–3448.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Scheid BH, Ashourvan A, Stiso J, Davis KA, Mikhail F, Pasqualetti F, Litt B, Bassett DS: Time-evolving controllability of effective connectivity networks during seizure progression. Proc Natl Acad Sci U S A. 2021;118(5):e2006436118. https://doi.org/10.1073/pnas.2006436118.

  23. Parkes L, Moore TM, Calkins ME, Cieslak M, Roalf DR, Wolf DH, Gur RC, Gur RE, Satterthwaite TD, Bassett DS: Network controllability in transmodal cortex predicts positive psychosis spectrum symptoms. Biol Psychiatry. 2021;90(6):409–18.

  24. Cui Z, Stiso J, Baum GL, Kim JZ, Roalf DR, Betzel RF, Gu S, Lu Z, Xia CH, He X et al: Optimization of energy state transition trajectory supports the development of executive function during youth. Elife. 2020;9:e53060. https://doi.org/10.7554/eLife.53060.

  25. Norman RM, Malla AK: Duration of untreated psychosis: a critical examination of the concept and its importance. Psychol Med 2001, 31(3):381–400.

    Article  CAS  PubMed  Google Scholar 

  26. Cammoun L, Gigandet X, Meskaldji D, Thiran JP, Sporns O, Do KQ, Maeder P, Meuli R, Hagmann P: Mapping the human connectome at multiple scales with diffusion spectrum MRI. J Neurosci Methods 2012, 203(2):386–397.

    Article  PubMed  Google Scholar 

  27. Hagmann P, Cammoun L, Gigandet X, Meuli R, Honey CJ, Wedeen VJ, Sporns O: Mapping the structural core of human cerebral cortex. PLoS Biol 2008, 6(7):e159.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Beaulieu C: The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed 2002, 15(7-8):435–455.

    Article  PubMed  Google Scholar 

  29. Brown CJ, Miller SP, Booth BG, Andrews S, Chau V, Poskitt KJ, Hamarneh G: Structural network analysis of brain development in young preterm neonates. Neuroimage 2014, 101:667–680.

    Article  PubMed  Google Scholar 

  30. Yeo BT, Krienen FM, Sepulcre J, Sabuncu MR, Lashkari D, Hollinshead M, Roffman JL, Smoller JW, Zollei L, Polimeni JR et al: The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J Neurophysiol 2011, 106(3):1125–1165.

    Article  PubMed  Google Scholar 

  31. Baum GL, Ciric R, Roalf DR, Betzel RF, Moore TM, Shinohara RT, Kahn AE, Vandekar SN, Rupert PE, Quarmley M et al: Modular segregation of structural brain networks supports the development of executive function in youth. Curr Biol 2017, 27(11):1561-1572.e1568.

    Article  Google Scholar 

  32. Stiso J, Khambhati AN, Menara T, Kahn AE, Stein JM, Das SR, Gorniak R, Tracy J, Litt B, Davis KA et al: White matter network architecture guides direct electrical stimulation through optimal state transitions. Cell Rep 2019, 28(10):2554-2566.e2557.

    Article  Google Scholar 

  33. Yan G, Vértes PE, Towlson EK, Chew YL, Walker DS, Schafer WR, Barabási AL: Network control principles predict neuron function in the Caenorhabditis elegans connectome. Nature 2017, 550(7677):519–523.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Betzel RF, Gu S, Medaglia JD, Pasqualetti F, Bassett DS: Optimally controlling the human connectome: the role of network topology. Sci Rep 2016, 6:30770.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Karrer TM, Kim JZ, Stiso J, Kahn AE, Pasqualetti F, Habel U, Bassett DS: A practical guide to methodological considerations in the controllability of structural brain networks. J Neural Eng 2020, 17(2):026031.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Muldoon SF, Pasqualetti F, Gu S, Cieslak M, Grafton ST, Vettel JM, Bassett DS: Stimulation-based control of dynamic brain networks. PLoS Comput Biol 2016, 12(9):e1005076.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Hagmann P, Sporns O, Madan N, Cammoun L, Pienaar R, Wedeen VJ, Meuli R, Thiran JP, Grant PE: White matter maturation reshapes structural connectivity in the late developing human brain. Proc Natl Acad Sci U S A 2010, 107(44):19067–19072.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Lebel C, Treit S, Beaulieu C: A review of diffusion MRI of typical white matter development from early childhood to young adulthood. NMR Biomed 2019, 32(4):e3778.

    Article  PubMed  Google Scholar 

  39. Whitfield-Gabrieli S, Thermenos HW, Milanovic S, Tsuang MT, Faraone SV, McCarley RW, Shenton ME, Green AI, Nieto-Castanon A, LaViolette P et al: Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc Natl Acad Sci U S A 2009, 106(4):1279–1284.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Jang JH, Jung WH, Choi JS, Choi CH, Kang DH, Shin NY, Hong KS, Kwon JS: Reduced prefrontal functional connectivity in the default mode network is related to greater psychopathology in subjects with high genetic loading for schizophrenia. Schizophr Res 2011, 127(1-3):58–65.

    Article  PubMed  Google Scholar 

  41. Whitfield-Gabrieli S, Ford JM: Default mode network activity and connectivity in psychopathology. Annu Rev Clin Psychol 2012, 8:49–76.

    Article  PubMed  Google Scholar 

  42. Kottaram A, Johnston LA, Cocchi L, Ganella EP, Everall I, Pantelis C, Kotagiri R, Zalesky A: Brain network dynamics in schizophrenia: Reduced dynamism of the default mode network. Hum Brain Mapp 2019, 40(7):2212–2228.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Sweeney JA, Mintun MA, Kwee S, Wiseman MB, Brown DL, Rosenberg DR, Carl JR: Positron emission tomography study of voluntary saccadic eye movements and spatial working memory. J Neurophysiol 1996, 75(1):454–468.

    Article  CAS  PubMed  Google Scholar 

  44. Pujol N, Penadés R, Junqué C, Dinov I, Fu CH, Catalán R, Ibarretxe-Bilbao N, Bargalló N, Bernardo M, Toga A et al: Hippocampal abnormalities and age in chronic schizophrenia: morphometric study across the adult lifespan. Br J Psychiatry 2014, 205(5):369–375.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Howes OD, McCutcheon R, Owen MJ, Murray RM: The role of genes, stress, and dopamine in the development of schizophrenia. Biol Psychiatry 2017, 81(1):9–20.

    Article  CAS  PubMed  Google Scholar 

  46. Mattai AA, Weisinger B, Greenstein D, Stidd R, Clasen L, Miller R, Tossell JW, Rapoport JL, Gogtay N: Normalization of cortical gray matter deficits in nonpsychotic siblings of patients with childhood-onset schizophrenia. J Am Acad Child Adolesc Psychiatry 2011, 50(7):697–704.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors want to express their sincere gratitude to all the staffs and students who participated in the data collection of this study.

Funding

This study was supported by the National Natural Science Foundation of China (Project Nos. 82120108014, 82071908, 82101998 and 82102000), Sichuan Science and Technology Program (Project Nos. 2021JDTD0002 and 2020YJ0018), Science and Technology Project of the Health Commission of Sichuan Province (Project No. 20PJ010), Fundamental Research Funds for the Central Universities (Project No. 2020SCU12053), 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University (Project Nos. ZYYC08001 and ZYJC18020), and Post-Doctor Research Project, West China Hospital, Sichuan University (Grant No. 2020HXBH005). Dr. Su Lui acknowledges the support from Humboldt Foundation Friedrich Wilhelm Bessel Research Award and Chang Jiang Scholars (Program No. T2019069).

Author information

Author notes

  1. Biqiu Tang and Wenjing Zhang contributed equally to this work and shared first authorship.

Authors and Affiliations

  1. Huaxi MR Research Center (HMRRC), Functional and Molecular Imaging Key Laboratory of Sichuan Province, Department of Radiology, West China Hospital of Sichuan University, No. 37 Guoxue Xiang, 610041, Chengdu, Sichuan, China

    Biqiu Tang, Wenjing Zhang, Na Hu, Qiyong Gong & Su Lui

  2. Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, 610041, Chengdu, Sichuan, China

    Biqiu Tang, Wenjing Zhang, Na Hu, Qiyong Gong & Su Lui

  3. School of Computer Science and Engineering, University of Electronic Science and Technology of China, No. 2006 Xiyuan Avenue, West Hi-Tech Zone, 611731, Chengdu, China

    Shikuang Deng, Jiang Liu & Shi Gu

Authors
  1. Biqiu Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wenjing Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shikuang Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jiang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Na Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Qiyong Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shi Gu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Su Lui
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Drs. Gong, Gu and Lui designed the research. Drs. Tang and Zhang collected the data and preprocessed the DTI data. Drs. Gu, Deng and Mr. Liu conducted the controllability analyses. Dr. Hu supervised the data collection and imaging processing. Drs. Tang and Zhang conducted statistical analysis together, and interpreted the findings. Dr. Tang made the figures and tables, whilst Dr. Zhang provided guidance and suggestions to improve them. Dr. Tang wrote the first draft of this manuscript, and Drs. Zhang and Lui revised the paper. All authors reviewed the paper for important intellectual content and gave final approval of the version to be published.

Corresponding authors

Correspondence to Shi Gu or Su Lui.

Ethics declarations

Ethics approval and consent to participate

All procedures performed in studies involving human participants were in accordance with the ethical guidelines and regulations of the institutional and/or national research committee and with the Helsinki declaration. The study was approved by the Ethics Committee of West China Hospital, Sichuan University. All participants provided written informed consent for study procedures, and informed consent for schizophrenia patients and minors below 16 years of age, was obtained from their parents or legal guardians.

Consent for publication

Not applicable.

Competing interests

Dr. Wenjing Zhang consults to VeraSci. The remaining authors have no competing interests or financial support to disclose.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tang, B., Zhang, W., Deng, S. et al. Age-associated network controllability changes in first episode drug-naïve schizophrenia. BMC Psychiatry 22, 26 (2022). https://doi.org/10.1186/s12888-021-03674-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12888-021-03674-5

Keywords

BMC Psychiatry

ISSN: 1471-244X

Contact us